Europe Cell-based Assays Market - Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE CELL BASED ASSAYS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 EUROPE CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)

2.8 DBMR MARKET POSITION GRID

2.9 DBMR VENDOR SHARE ANALYSIS

2.10 MULTIVARIATE MODELING

2.11 PRODUCTS LIFELINE CURVE

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES

3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES

3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE

3.2 RESTRAINT

3.2.1 STRINGENT REGULATORY REQUIREMENTS

3.2.2 HIGH COST OF INSTRUMENTATION

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS

3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS

3.4 CHALLENGES

3.4.1 CHALLENGING ANALYSIS PROCEDURE

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE CELL-BASED ASSAYS MARKET, BY TYPE

6.1 OVERVIEW

6.2 CELL VIABILITY ASSAY

6.3 CYTOTOXICITY ASSAY

6.4 CELL PROLIFERATION ASSAY

6.5 CELL DEATH ASSAY

6.6 OTHERS

7 EUROPE CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 ASSAY KITS

7.2.2 CELL LINES

7.2.2.1 PRIMARY CELL LINES

7.2.2.2 STEM CELL LINES

7.2.2.3 IMMORTALIZED CELL LINES

7.2.3 REAGENTS

7.2.4 MICROPLATES

7.3 SERVICES

7.4 INSTRUMENTS AND SOFTWARE

8 EUROPE CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 HIGH THROUGHPUT SCREENING

8.3 FLOW CYTOMETRY

8.4 HIGH CONTENT SCREENING

8.5 LABEL FREE DETECTION

9 EUROPE CELL-BASED ASSAYS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DISCOVERY

9.2.1 PREDICTIVE TOXICOLOGY

9.2.2 PHARMACODYNAMIC STUDIES

9.2.3 ADME RESEARCH

9.3 BASIC RESEARCH

9.4 OTHERS

10 EUROPE CELL-BASED ASSAYS MARKET, BY END USER

10.1 OVERVIEW

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.3 CONTRACT RESEARCH ORGANIZATIONS

10.4 ACADEMIC & RESEARCH INSTITUTIONS

10.5 GOVERNMENT ORGANIZATIONS

10.6 OTHERS

11 EUROPE CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT

11.3 INDIRECT

12 EUROPE CELL BASED ASSAY MARKET, BY GEOGRAPHY

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 UNITED KINGDOM

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 NETHERLANDS

12.1.8 SWITZERLAND

12.1.9 BEGIUM

12.1.10 TURKEY

12.1.11 REST OF EUROPE

13 EUROPE CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 EUROPE CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 COMPANY PROFILE

15.1 GENERAL ELECTRIC

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 DANAHER

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 AGILENT TECHNOLOGIES, INC.

15.3.1.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 THERMO FISHER SCIENTIFIC INC

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 MERCK KGAA

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 PERKINELMER INC, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BIO-RAD LABORATORIES, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 ATCC

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 AURELIA BIOSCIENCE LTD.

15.9.1 COMPANY SNAPSHOT

15.9.2 SERVICE PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.10 BD

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENTS

15.11 BIOAGILYTIX LABS

15.11.1 COMPANY SNAPSHOT

15.11.2 SERVICE PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BIOVISION INC.

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CELL SIGNALING TECHNOLOGY, INC.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 CISBIO

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 ENZO BIOCHEM INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENT

15.16 EUROFINS SCIENTIFIC

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT AND SERVICE PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 LAKEPHARMA, INC.

15.17.1 COMPANY SNAPSHOT

15.17.2 SERVICE PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 LONZA

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 SERVICE PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 MILTENYI BIOTEC

15.19.1 COMPANY SNAPSHOT

15.19.2.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.20 XENO DIAGNOSTICS, LLC.

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

UU

TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)

TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)

TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 4 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 5 EUROPE CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 EUROPE CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 EUROPE CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 EUROPE CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 11 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 13 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 14 EUROPE SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 EUROPE INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 17 EUROPE HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 EUROPE FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 EUROPE HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 22 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 27 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 33 EUROPE DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 36 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 37 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 38 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 39 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 41 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 42 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 44 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 GERMANY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 46 GERMANY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 47 GERMANY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 48 GERMANY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 49 GERMANY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 50 GERMANY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 51 GERMANY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 52 GERMANY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 53 FRANCE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 54 FRANCE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 55 FRANCE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 56 FRANCE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 57 FRANCE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 58 FRANCE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 FRANCE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 FRANCE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 61 FRANCE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 62 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 63 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 UNITED KINGDOM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 UNITED KINGDOM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 66 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 67 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 UNITED KINGDOM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 70 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 71 ITALY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 72 ITALY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 73 ITALY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 74 ITALY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 75 ITALY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 76 ITALY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 77 ITALY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 78 ITALY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 79 ITALY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 80 SPAIN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 81 SPAIN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 82 SPAIN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 83 SPAIN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 84 SPAIN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 85 SPAIN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 86 SPAIN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 87 SPAIN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 88 SPAIN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 89 RUSSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 90 RUSSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 91 RUSSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 92 RUSSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 93 RUSSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 94 RUSSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 95 RUSSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 96 RUSSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 97 RUSSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 98 NETHERLANDS CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 99 NETHERLANDS CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 100 NETHERLANDS CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 101 NETHERLANDS CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 102 NETHERLANDS CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 103 NETHERLANDS CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 104 NETHERLANDS DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 105 NETHERLANDS CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 106 NETHERLANDS CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 107 SWITZERLAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 108 SWITZERLAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 109 SWITZERLAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 110 SWITZERLAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 111 SWITZERLAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 112 SWITZERLAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 113 SWITZERLAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 114 SWITZERLAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 115 SWITZERLAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 116 BELGIUM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 117 BELGIUM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 118 BELGIUM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 119 BELGIUM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 120 BELGIUM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 121 BELGIUM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 122 BELGIUM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 123 BELGIUM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 124 BELGIUM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 125 TURKEY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 126 TURKEY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 127 TURKEY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 128 TURKEY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 129 TURKEY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)

TABLE 130 TURKEY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 131 TURKEY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 132 TURKEY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 133 TURKEY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 134 REST OF EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)